Both CD3 + /CD4 + and CD3 + /CD8 + T-cell as well as CD68 + /CD163 + hot tumours were significantly associated with high PD-L1 expression scores, which might be relevant for therapy of squamous bladder cancer with pembrolizumab. This evidence concerns the gene CD163 and neoplasm.